Meet Senzime at the Swiss-Scandinavian Bio-Business Seminar
The 10thSwiss-Scandinavian Bio-Business Seminar is organized by the Nordic countries in cooperation with Swiss partners. During this high-level partnering and investor conference, Swiss and Nordic biotech and pharmaceutical companies as well as investors meet in one-to-one meetings and present themselves in plenum.
The goal of the conference and by means of the Swiss-Nordic focus is to establish new contacts and networks. The conference has a broad focus within biotech, pharma and medical device and gathers small, early stage companies as well as global, commercial corporations.
The conference is open for biotech and pharma companies as well as investors within the life science industry.
When: February 10, 2016 from 08:00-18:00
Where: SIX Stock Exchange building in Zurich.
TO THE EDITORS
Senzime develops and markets analytical instruments and related disposable products for automated, continuous monitoring of vital substances, e.g. glucose and lactate, in biological fluids. Senzime offers complete patient monitoring systems for the health care market with products e.g. CliniSenz Analyzer and OnZurf Probe. Senzime offers a complete system enabling continuous monitoring via microdialysis in tissue or blood which is critical to detect post-surgery complications. The company's share is listed on Aktietorget since 2008. www.senzime.com